peptides (ophthalmic, ocular pain) (Catalyst)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namepeptides (ophthalmic, ocular pain) (Catalyst)
Drug Alias Namepeptides (ophthalmic, ocular pain) (Sarentis Therapeutics)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsEye Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSarentis Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSarentis Therapeutics IncCatalyst
Active IndicationsN/A
Inactive IndicationsEye Pain

Other Information

ATC CodeN/A
Related LinksN/A